Document Detail

Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin.
MedLine Citation:
PMID:  2228814     Owner:  NLM     Status:  MEDLINE    
A pregnant woman and the fetus she carries face health risks from many sources. One risk that requires ongoing vigilance is the use of prescription drugs during pregnancy. The international health care community has been sensitized to the risks of drug use during pregnancy because of three pharmaceuticals that have caused widespread crises for mothers and their offspring. The crises that diethylstilbestrol, thalidomide, and, to a lesser extent, Bendectin have created in the past four decades are reviewed in this article. The lessons these drug crises can teach us are articulated in the belief that similar crises may be averted in the future.
E J Saunders; J A Saunders
Related Documents :
415754 - Maternal anticonvulsants and optic nerve hypoplasia.
17666074 - Idiopathic generalized epilepsy with absences: syndrome classification.
1574184 - Epilepsy, pregnancy, and major birth anomalies: an italian prospective, controlled study.
22122754 - Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or w...
3889164 - A monoclonal antibody based solid-phase enzyme-binding assay to measure levels of place...
21110524 - Pregnancy dermatoses: diagnosis, management, and controversies.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Health care for women international     Volume:  11     ISSN:  0739-9332     ISO Abbreviation:  Health Care Women Int     Publication Date:  1990  
Date Detail:
Created Date:  1990-12-06     Completed Date:  1990-12-06     Revised Date:  2010-07-15    
Medline Journal Info:
Nlm Unique ID:  8411543     Medline TA:  Health Care Women Int     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  423-32     Citation Subset:  N; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / epidemiology,  etiology*
Antiemetics / adverse effects*
Diethylstilbestrol / adverse effects*
Doxylamine / adverse effects*
Drug Combinations
Drug Industry
Infant, Newborn
Physician-Patient Relations
Public Opinion*
Pyridoxine / adverse effects*
Thalidomide / adverse effects*
Reg. No./Substance:
0/Antiemetics; 0/Drug Combinations; 0/dicyclomine, doxylamine, pyridoxine drug combination; 469-21-6/Doxylamine; 50-35-1/Thalidomide; 56-53-1/Diethylstilbestrol; 65-23-6/Pyridoxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sleep and the reproductive cycle: a review.
Next Document:  Early patterns of maternal attachment.